Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SLS compared with CLS: revenue, margins and what each company keeps, and the suppliers and customers both name
SLS
SELLAS Life Sciences Group, Inc.
Change
Mkt cap
Revenue
Revenue
CLS
Celestica Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
SLS
SELLAS Life Sciences Group, Inc.
vs
CLS
Celestica Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only SLS
9
MRK
Merck
supplier
BMY
Bristol-Myers Squibb
supplier
—
GenFleet Therapeutics (Shanghai)
unlisted
supplier
—
Memorial Sloan Kettering Cancer Center
unlisted
supplier
5 more · SLS chain
›
Shared
0
No shared counterparties.
Only CLS
5
—
Undisclosed CCS customer (32% of revenue in 2025)
unlisted
customer
—
Undisclosed CCS customer (32% of total revenue in 2025)
unlisted
customer
IBM
IBM
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
Onex
unlisted
supplier
1 more · CLS chain
›
SLS
SELLAS Life Sciences Group, Inc.
Change
8.72
▲
+3.56%
Mkt cap
$1.7B
Revenue
—
Revenue
—
CLS
Celestica Inc
Change
219.61
▲
+6.25%
Regular session
Nov 9 '26
Mkt cap
$26.1B
Revenue
$5.8B
Q3 FY26
Revenue
$12.4B
FY25
vs
Compare
Regular session
Nov 9 '26
SLS
SELLAS Life Sciences Group, Inc.
vs
CLS
Celestica Inc
8.72
▲
+3.56%
Price
219.61
▲
+6.25%
$1.7B
Mkt cap
$26.1B
—
Revenue
$5.8B
Q3 FY26
—
Revenue
$12.4B
FY25
Change
Change
SLS
8.72
▲
+3.56%
vs
CLS
219.61
▲
+6.25%
Regular session
Nov 9 '26